Literature DB >> 3051835

Causes and effects of the low T3 syndrome during caloric deprivation and non-thyroidal illness: an overview.

G Hennemann1, R Docter, E P Krenning.   

Abstract

The increased serum reverse T3 and decreased T3 during caloric deprivation and non-thyroidal illness is caused by decreased T3 production (with intact degradation) and reversed T3 degradation (with intact production) respectively. These changes can ensue from two mechanisms i.e. decreased 5'D of T4 and of reverse T3 (possibly caused by a decrease in naturally occurring reducing agents) or by decreased transport of T4 and reverse T3 into the liver (possibly caused by decreased ATP concentrations in the liver). The effects of the low T3 syndrome at the tissue level are in many instances comparable to those seen in hypothyroidism. The effects lead to conservation of energy and decrease of protein breakdown. These effects are considered to constitute a beneficial adaptative mechanism in situations in which the organism is endangered. There is no evidence that treatment of patients with the low T3 syndrome with thyroid hormones is of any benefit. Knowledge at the present moment suggests that administration of thyroid hormones during caloric deprivation or non-thyroidal illness should be avoided.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3051835

Source DB:  PubMed          Journal:  Acta Med Austriaca        ISSN: 0303-8173


  8 in total

1.  Tri-iodothyronine supplement protects gut barrier in septic rats.

Authors:  Zhi-Li Yang; Lian-Yue Yang; Geng-Wen Huang; He-Li Liu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

2.  Analogous effects of serum lipids from patients with nonthyroidal illness and normal subjects on the uptake of thyroxine and its conversion to triiodothyronine by rat hepatocytes in culture.

Authors:  K Kluetsch; A Hotze; G S Rao
Journal:  Clin Investig       Date:  1993-01

3.  Low free T3 to free T4 ratio was associated with low muscle mass and impaired physical performance in community-dwelling aged population.

Authors:  S H Kong; J H Kim; Y J Park; J H Lee; A R Hong; C S Shin; N H Cho
Journal:  Osteoporos Int       Date:  2019-11-29       Impact factor: 4.507

Review 4.  Thyroid hormones and antioxidant systems: focus on oxidative stress in cardiovascular and pulmonary diseases.

Authors:  Antonio Mancini; Sebastiano Raimondo; Chantal Di Segni; Mariasara Persano; Giovanni Gadotti; Andrea Silvestrini; Roberto Festa; Luca Tiano; Alfredo Pontecorvi; Elisabetta Meucci
Journal:  Int J Mol Sci       Date:  2013-12-09       Impact factor: 5.923

Review 5.  Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings.

Authors:  Arnaldo Moura Neto; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2016-10-10       Impact factor: 3.257

6.  Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants.

Authors:  Lay Ong Tan; Mary Grace Tan; Woei Bing Poon
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

7.  Association between the serum concentration of triiodothyronine with components of metabolic syndrome, cardiovascular risk, and diet in euthyroid post-menopausal women without and with metabolic syndrome.

Authors:  Fabiola Luna-Vazquez; Rosalía Cruz-Lumbreras; Julia Rodríguez-Castelán; Margarita Cervantes-Rodríguez; Jorge Rodríguez-Antolín; Omar Arroyo-Helguera; Francisco Castelán; Margarita Martínez-Gómez; Estela Cuevas
Journal:  Springerplus       Date:  2014-05-24

8.  Serum Concentration of Thyroid Hormones Long-Term after Sulfur Mustard Exposure.

Authors:  Sakine Moaiedmohseni; Tooba Ghazanfari; Ensie Sadat Mirsharif; Nayere Askari; Zuhair Mohammad Hassan; Mohammad Mehdi Naghizadeh; Soghrat Faghihzadeh; Fereidoun Azizi
Journal:  Iran J Public Health       Date:  2019-05       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.